Microvascular Angiopathic Consequences of COVID-19
- PMID: 33604359
- PMCID: PMC7884319
- DOI: 10.3389/fcvm.2021.636843
Microvascular Angiopathic Consequences of COVID-19
Abstract
The coronavirus disease-2019 (COVID-19) pandemic has rapidly spread across the world. The disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan, China in December, 2019. Ever increasing data is continuing to emerge about the impact of COVID-19 on cardiovascular tissue and other organ system. Clinical features associated with COVID-19 suggest that endothelial cell dysfunction and microvascular thrombosis are to a large extent contributing to resultant multi-organ complications. This review is aimed at highlighting the critical aspects associated with COVID-19 and its presumed microvascular angiopathic consequences on the cardiovascular system leading to multi-organ dysfunction.
Keywords: COVID-19; angiopathy; cardiac dysfunction; micovascular disease; vascular thrombosis.
Copyright © 2021 Nalugo, Schulte, Masood and Zayed.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources